{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-061230","form_type":"8-K","ticker":"OCGN","cik":"0001372299","company_name":"Ocugen, Inc.","filed_at":"2026-05-14T20:30:23+00:00","discovered_at":"2026-05-14T20:32:00.297984+00:00","generated_at":"2026-05-14T20:39:45.727896+00:00","sec_items":["2.03","1.01","3.02","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Ocugen closes $130M of 6.75% convertible senior notes due 2034, net proceeds ~$112.6M","bullets":["Closed $130.0M aggregate principal of 6.75% Convertible Senior Notes due 2034, including full $15M over-allotment exercise.","Net proceeds ~$112.6M after discount and expenses; offering price was 90% of principal.","Used $32.7M to fully repay outstanding loan under Avenue Capital Group agreement plus prepayment fees.","Remaining net proceeds for general corporate purposes; cash runway extended into 2028.","CEO cites momentum to advance three late-stage programs targeting three BLA filings by 2028."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-061230","json":"https://secwatch.observer/filing/0001104659-26-061230.json","markdown":"https://secwatch.observer/filing/0001104659-26-061230.md","text":"https://secwatch.observer/filing/0001104659-26-061230.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372299/000110465926061230/0001104659-26-061230-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372299/000110465926061230/tm2614578d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T20:39:45.727896+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5aa60461a2ca1b88c691a66c46df023babcc64c7","claim":"Ocugen, Inc. incurred convertible notes of $15.0 million aggregate principal amount with U.S. Bank Trust Company, National Association at 6.75% maturing due 2034.","evidence_excerpt":"On May 14, 2026, the Company issued an additional $15.0 million aggregate principal amount of notes (the \"additional notes\") pursuant to the exercise in full of the over-allotment option granted by the Company to the initial purchaser in the offering.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372299/000110465926061230/0001104659-26-061230-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$15.0 million aggregate principal amount"},{"label":"Counterparty","value":"U.S. Bank Trust Company, National Association"},{"label":"Rate","value":"6.75%"},{"label":"Maturity","value":"due 2034"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"f01f808e8546a5d0beee59d301288413500e25ce","claim":"Ocugen, Inc. entered into purchase agreement with initial purchaser (effective 2026-05-04).","evidence_excerpt":"The Company offered and sold the additional notes to the initial purchaser in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372299/000110465926061230/0001104659-26-061230-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"initial purchaser"},{"label":"Effective","value":"2026-05-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}